Home » CEPHALON DRUG GETS WIDER USE IN GERMANY
CEPHALON DRUG GETS WIDER USE IN GERMANY
Cephalon Inc. received authorization from the Federal Institute for Drugs and Devices in Germany to market modafinil tablets as a treatment of moderate to severe chronic shift work sleep disorder. The drug, marketed under the trade name Vigil, has been available in Germany since 1998 as a treatment for narcolepsy. Cephalon (NASDAQ: CEPH), based in Frazer, Pa., sells the drug as Provigil in the United States, where it is approved for excessive sleepiness associated with a variety of disorders.
Philadelphia Business Journal (http://www.bizjournals.com/philadelphia/stories/2005/08/29/daily17.html?from_rss=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May